-
Cancer Researchers See Iron as Potential Path to Mesothelioma Cell Death
“Death by iron” may sound like a line out of the show Game of Thrones, but according to cell biologist Xuejun Jiang of the Sloan Kettering Institute, it may actually be the key to preventing the formation of malignant mesothelioma tumors, and even to killing metastatic mesothelioma cells. Dr. Jiang and his colleagues have been investigating ferroptosis,
-
Cancer Center in Tennessee First in U.S. to Offer New FDA-Approved Mesothelioma Treatment
Last May, the U.S. Food and Drug Administration announced that it had approved the use of the NovoTTF-100L System in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM). Now, West Cancer Center in Tennessee has announced that it will be the first oncology center
-
Mesothelioma Patients With Genetic Mutation Have Greater Success With Chemotherapy
We’ve long known that our genes dictate characteristics like eye color and height, but a new study conducted by the National Cancer Institute is indicating that genes can also determine how well mesothelioma patients respond to chemotherapy. Raffit Hassan, M.D., a special investigator with the National Cancer Institute’s Center for Cancer Research, led the study
-
Upcoming Meeting to Feature News on Latest Mesothelioma Study
Later this month, the European Society for Medical Oncology (ESMO) will be holding its annual meeting in Barcelona, Spain, and one of the most anticipated studies that will be presented is a malignant mesothelioma trial that pharmaceutical and biotech industry news site Vantage.com is saying “threatens to steal the limelight” from the rest of presentations scheduled
-
Electrician’s Mesothelioma Lawsuit Allowed to Proceed, Despite Asbestos Company Objections
George C. Proctor died of malignant mesothelioma on March 23rd, 2019, just a year after he was first diagnosed with the rare form of cancer. Though he had little time between diagnosis and death, Mr. Proctor was able to file a mesothelioma lawsuit against several companies whose products he held responsible for exposing him to
-
New Lymph Node Testing Can Save Patients From Unnecessary Mesothelioma Surgery
Though medical science has come a long way in its understanding of malignant mesothelioma, it still has a long way to go. The rare and deadly form of cancer that is caused by exposure to asbestos is notoriously difficult to treat. It can also be difficult to diagnose. With this in mind, researchers from Canada
-
Treatment Disparities Among Mesothelioma Patients Discussed At Conference
The annual World Conference on Lung Cancer was held last week in Barcelona, Spain, and among the topics covered by international researchers and presenters was a little-discussed reality in treatment disparities among patients diagnosed with malignant mesothelioma. Emanuela Taioli, MD, director of the Institute for Translational Epidemiology and the Center for the Study of Thoracic
-
Phase 2 Study of Novel Gene Therapy for Mesothelioma Begins at Baylor
Biotherapeutics company Momotaro-Gene has announced the beginning of a Phase 2 clinical trial on their innovative treatment for malignant mesothelioma. The study will analyze the efficacy of the company’s novel gene therapy called MTG201 combined with the PD-1 inhibitor nivolumab (Opdivo) on patients whose cancer has returned. Treatment being tested on patients who have relapsed
-
Jury Finds J & J Caused Mesothelioma, Orders Payment of $37.2 Million to 4 Victims
After hearing weeks of testimony, a New Jersey jury has sided with four people who blame Johnson & Johnson’s baby powder and other talc-based powders for their malignant mesothelioma. The jury ordered the consumer giant to pay the victims — Douglas Barden, 65, David Etheridge, 57, D’Angela McNeill-George, 41, and Will Ronning, 46 — at
-
Each Year, More 9/11 Survivors Die of Malignant Mesothelioma
Every year since 2001, the nation pauses to remember those who died in the terrorist attacks on the Pentagon and World Trade Center on September 11th. And every year, the number of actual victims of those attacks grows as a result of people dying from related diseases, including malignant mesothelioma. Many believe that by the
-
New Early Lung Cancer Test May Help Diagnose Malignant Pleural Mesothelioma
When researchers at the 2019 World Conference on Lung Cancer announced they’d seen positive results from a new early lung cancer detection tool, it raised the hopes of mesothelioma physicians around the world. The rare and fatal form of lung cancer caused by exposure to asbestos is notoriously difficult to treat, and one of the
-
Why Mesothelioma Patients Need Advance Care Planning
If you or someone you love has been diagnosed with malignant mesothelioma, there are an awful lot of decisions that need to be made about the type of medical treatments you wish to submit to. It is important to put thought into what you want done to help improve your situation. It makes equal sense
-
Auto Mechanic Wins $8.4 Million Mesothelioma Verdict Against Ford Motor Co.
A St. Louis jury ordered Ford Motor Company to pay $8.433 million in compensation to lifelong resident Al Bennett and his wife Pam after hearing evidence that the company had exposed him to asbestos, leading to his diagnosis with malignant pleural mesothelioma. Mesothelioma is a fatal form of cancer that affects the lining of the
-
Judge in Johnson & Johnson Mesothelioma Case Rebukes Company’s Attorney
Mesothelioma victims are often torn about whether to pursue legal action against the companies responsible for their illness: the idea of battling giant asbestos companies can be intimidating. But those affected by asbestos can take heart from what happened this week in a New Jersey courtroom. Middlesex County Superior Court Judge Anna C. Viscomi struck
-
Chinese Mesothelioma Researchers Create Highly Accurate Tool to Predict Survival
When a person is diagnosed with malignant mesothelioma and informed that the condition is always considered terminal, one of the first questions that they ask is about how much time they have left. Now, a new visual tool created by cancer researchers at China’s Peking University may be able to provide a highly accurate answer,
-
UK Mesothelioma Fund Memorializes Renowned Advocate
In the United Kingdom, the June Hancock Mesothelioma Fund is one of the top charities dedicated to raising money to support research and provide aid surrounding malignant mesothelioma. The charity is named for June Hancock, a woman who died of the asbestos-related illness, but not before winning a significant legal victory against the American-based company
-
Drug Study Provides Mixed Results for Mesothelioma Patients
Researchers from The University of Teas MD Anderson Cancer Center in Houston recently concluded a study of a drug called Cediranib to determine whether it could provide any benefit to patients diagnosed with malignant pleural mesothelioma. Though they found that cediranib did offer a small survival benefit to patients when combined with chemotherapy, the researches
-
Multi-Year Mesothelioma Lawsuit Ends With $2.38 Million Jury Verdict for Widow
Thomasina Fowler’s initial wrongful death lawsuit against Union Carbide was filed in June of 2011, when she accused the chemical company of being responsible for her husband’s death from malignant mesothelioma. In 2015 the company was granted summary judgment after they argued that there wasn’t enough information to prove that Charley Edenfield had worked directly
-
What is A Biomarker, and What Do They Tell Us About Mesothelioma?
When it comes to diagnosing malignant mesothelioma, physicians have several tools available. Doctors rely on the information that their patients provide about their history of exposure to asbestos, as well as the symptoms that they display, and based upon that information they order imaging studies, blood tests and biopsies. While X-rays and cat scans look
-
Study Shows Older Mesothelioma Patients Less Likely To Have Chemotherapy
Research conducted by the Asbestos Diseases Research Institute in Sydney, Australia is calling into question whether old mesothelioma patients are being treated with the same attention as is true of their younger counterparts. The study showed that among more than 900 mesothelioma patients, the older a patient was at the time of diagnosis, the lower
